Dickkopf-1: a suitable target for the management of myeloma bone disease

Author： Gavriatopoulou Maria   Dimopoulos Meletios-Athanasios   Christoulas Dimitrios   Migkou Magdalini   Iakovaki Marina   Gkotzamanidou Maria   Terpos Evangelos  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.7, 2009-07, pp. : 839-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dickkopf-1 as a potential therapeutic target in Paget's disease of bone

By McCarthy Helen S   Marshall Michael J  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 2, 2010-02 ,pp. : 221-230

Informa Healthcare

Access to resources Recommend Favorite

Advances in the management of myeloma bone disease

By Shipman Claire M   Oyajobi Babatunde O   Mundy Gregory R  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2781-2791

Informa Healthcare

Access to resources Recommend Favorite

Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 7, 2009-01 ,pp. : 854-870

Bentham Science Publishers

Access to resources Recommend Favorite

CCR1 as a target for multiple myeloma

By Vallet Sonia   Anderson Kenneth C  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 9, 2011-09 ,pp. : 1037-1047

Informa Healthcare

Access to resources Recommend Favorite

Sclerostin: a possible target for the management of cancer-induced bone disease

By Gkotzamanidou Maria   Dimopoulos Meletios A   Kastritis Efstathios   Christoulas Dimitrios   Moulopoulos Lia A   Terpos Evangelos  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 8, 2012-08 ,pp. : 761-769

Informa Healthcare

Access to resources Recommend Favorite